Session 4 Panel Discussion- Leukemia Treatment Insights Acute Myelogenous Leukemia 1 Min Read0 Navigating the ever-evolving landscape of leukemia treatment has become an intricate endeavor, with recent clinical trials offering intriguing insights and…
Harry Paul Erba, MD- Midostaurin and Second-Gen Inhibitors Acute Lymphoblastic Leukemia 1 Min Read0 Harry Paul Erba, MD Professor of Medicine and Member of the Duke Cancer Institute Harry Erba, MD, a respected Duke…
